View from France: Can Europe overcome its reflexive anti-GMO bias?

Genetically modified organisms have almost become taboo in Europe. There is only one GMO cultivated in the European Union–Mosanto’s MON810 corn, which is only approved for sale in limited markets and has run into moratoriums enforced by several state-member governments. Approval for the Amflora potato made by BASF and used for paper-making was annulled last week. Both products are victims of anti-GMO sentiment. Yet, elsewhere in the world, in GM crops are being cultivated on a large scale. Marion Guillou, President and CEO of the French Institut national de recherche agronomique (INRA) from 2004 to 2012, spoke to ParisTech Review about the benefit-risk balance for GM products and analyzes why Europe continues to resist the technology.

 

Read the full, original story: The GMO debate – once more unto the breach…

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.